top of page

Our People

Academic Staff
​Prof. Vincent Chi-ho CHUNG 鍾志豪教授

Prof. Vincent Chi-ho CHUNG


B Chin Med, BSc Biomed Sci (HKBU), MSc Evid Based Healthcare (Oxford),

PhD Public Health (CUHK)

Associate Professor



ORCID: 0000-0002-5947-4492

Scopus Author ID: 868559460

ResearcherID: K-2447-2013

Academic Appointments

  • Convener (Education), Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong

  • US National Academy of Medicine (NAM) International Health Policy Fellow (2021-2023)

  • Hong Kong Health and Medical Research Fund Research Fellow (2019-2021)

  • Chair of Research Advisory Committee (2021-2023) and Elected Member of Board of Directors (2018-2021), International Society for Traditional, Complementary and Integrative Medicine Research

  • Head of Development Division, School of Chinese Medicine, The Chinese University of Hong Kong (2019-2022)

  • Guangdong Science and Technology Department Overseas Famous Teacher, School of Public Health, Southern Medical University, China (2022-2023)

  • Visiting Professor, Chengdu University of Traditional Chinese Medicine Hospital (2019-2022)

  • Visiting Associate Professor, School of Biological Sciences, Nanyang Technological University, Singapore (2020-2021)

  • Council Member of the Evidence based Healthcare Committee, Chinese Association of Integrative Medicine (2018-2020)

  • Visiting Research Fellow, Australian Research Centre in Complementary and Integrative Medicine, University Technology Sydney, Australia (2014-2020)


Dr. Vincent CH Chung is a registered Chinese medicine practitioner with training in both evidence-based healthcare and public health. As a Jockey Club Scholar, he received Bachelor of Chinese Medicine and Bachelor of Biomedical Science (First Class) from Hong Kong Baptist University. With support from the Li Po Chun Charitable Trust Fund – Overseas Postgraduate Study and Professional Training Scholarship, he completed his MSc in Evidence based Healthcare in Oxford University. He studied his PhD in Public Health at The Chinese University of Hong Kong, focusing on health policy and services research.


He is one of the few scholars with research spanning across clinical, public health, and policy aspects of Integrative Medicine. He envisions evidence-based integration of conventional and complementary healthcare by promoting rigorous research, policy advocacy, and quality education locally, nationally, and internationally. He has published more than 150 articles in international peer-reviewed academic journals, and ranked at the top 1.84% amongst all researchers in the category of Complementary & Alternative Medicine globally, according to the updated science-wide author databases of standardized citation indicators (PloS Biology 18.10 (2020): e3000918). He is subsequently ranked as the 2% top-cited scientists worldwide in 2021 (doi: 10.17632/btchxktzyw.5).


He served as a consultant for the WHO Western Pacific Regional Office in formulating strategy for using traditional and complementary medicine for promoting healthy aging, as well as an observer in the development process of the WHO Traditional Medicine Strategy. His published consultancy reports have influenced policy recommendations in the 2022 WHO Regional framework for harnessing traditional and complementary medicine for achieving health and well-being in the Western Pacific []. Aside from policy research, his methodological studies on systematic reviews have impacted Cochrane’s literature search recommendations [Cochrane Handbook for Systematic Reviews of Interventions (2019): 67-107]

Results from his randomized trials and evidence syntheses directly supported international clinical guideline recommendations of acupuncture in the management of functional dyspepsia [Gut 71.9 (2022): 1697-1723], irritable bowel syndrome [Journal of Gastroenterology 56.3 (2021): 193-217.], as well as in cancer palliative care [Supportive Care in Cancer 28.1 (2020): 23-33.].

He is the Principal Investigator of 10 external competitive research grants (5 from the Health and Medical Research Fund, 2 from Chinese Medicine Development Fund, 3 from commissioned research grants and research contracts). He has supervised / co-supervised 5 PhD students to completion and has contributed to 3 book chapters. He is Associate Editor of BMC Trials (Since 2019), BMC Complementary Medicine and Therapies (Since 2011) and Complementary Therapies in Medicine (2017-2020), and serves as editorial board member of European Journal of Integrative Medicine (Since 2013) and Scientific Reports (Since 2017).


He serves as External Examiner of the BSc Chinese Medicine program for the International Medical University, Malaysia (2021-2023). He has been an External Assessor (for promotion and substantiation) in Public Health for University Technology Sydney, and in Chinese Medicine for Western Sydney University and RMIT University, Australia. He reviewed grants for both international and local research funding bodies including EU / MSCA-Cofund doctoral program of the Swiss School of Public Health (SSPH+), Research and Development Administration Office of the University of Macau, and the Hong Kong Research Grants Council. He was appointed as External Examiner for PhD candidates at Western Sydney University.


On public and government services, he serves as a member of the Hong Kong SAR Government Chinese Medicine Development Committee (2018-2025), the Patient Experience Sub-committee of the Chinese Medicine Hospital Planning Office, as well as the Hospital Authority Chinese Medicine Sub-committee. He was also a member of the Registration Committee, Chinese Medicine Practitioner Board, Chinese Medicine Council of Hong Kong (2018-2021).

Research Interests

  • Evidence based healthcare

  • Implementation science

  • Clinical and policy research in Integrative Medicine

Recent Funded Research Projects 

As Principal Investigator:

  • Influence from the use of syndrome differentiation on treatment effect estimates in Chinese herbal medicine trials: meta-epidemiological study and network meta-analysis (Chinese Medicine Development Fund)

  • Complex interventions for reducing 30-day avoidable hospital readmission among adults: recommendations for Hong Kong via overview of systematic reviews and stakeholder consensus (Health and Medical Research Fund)

  • Theory-based Development of Implementation Interventions to Scale-up or Enhance Integrated Chinese-Western Medicine Services for Cancer Palliative Care (Chinese Medicine Development Fund)

  • Identifying Priority Research Questions for Addressing Unmet Cancer Palliative Care Needs Using Chinese Medicine with a Systematic Approach (Health and Medical Research Fund)

  • Data Driven Identification and Classification of Chinese Medicine Syndrome Types among Functional Dyspepsia Patients: Latent Tree Analysis (Health and Medical Research Fund Fellowship Scheme)

  • Electroacupuncture plus Standard Care for Managing Refractory Functional Dyspepsia: Pragmatic Randomized Trial with Economic Evaluation (Health and Medical Research Fund)

  • Electroacupuncture and Wrist Splinting for Carpal Tunnel Syndrome: A Randomized Trial Primary Care Setting (Health and Medical Research Fund)

Selected Publications

Theme 1: Integrative Chinese – Western Medicine in Oncology – From Evidence to Implementation

  1. Wu, X., Chung, V. C., Hui, E. P., Ziea, E. T., Ng, B. F., Ho, R. S., ... & Wu, J. C. (2015). Effectiveness of acupuncture and related therapies for palliative care of cancer: overview of systematic reviews. Scientific reports, 5(1), 1-15.

  2. Wong, C. H., Wu, I. X., Balneaves, L. G., Lo, R. S., Witt, C. M., Wu, J. C., ... & Chung, V. C. (2019). Prioritizing Chinese medicine clinical research questions in cancer palliative care: international Delphi survey. Journal of Pain and Symptom Management, 58(6), 1002-1014.

  3. Wong, C. H., Wu, I. X., Adams, J., Steel, A., Wardle, J., Wu, J. C., ... & Chung, V. C. (2020). Development of evidence-based Chinese medicine clinical service recommendations for cancer palliative care using Delphi approach based on the evidence to decision framework. Integrative Cancer Therapies, 19, 1534735420940418.

  4. Wong, C. H., Wong, W., Lin, W. L., Au, D. K., Wu, J. C., Leung, T. H., ... & Chung, V. C. (2021). Prioritizing Chinese medicine clinical research questions in cancer palliative care from patient and caregiver perspectives. Health Expectations, 24(4), 1487-1497.

Theme 2: Policy and Implementation Research in Integrative Medicine

  1. Chung, V. C., Ho, F. F., Lao, L., Liu, J., Lee, M. S., Chan, K. W., & Nilsen, P. (2022). Implementation Science in Traditional, Complementary and Integrative Medicine: An Overview of Experiences from China and the United States. Phytomedicine, 154591.

  2. Chung, V. C., Ho, L. T., Leung, T. H., & Wong, C. H. (2021). Designing delivery models of traditional and complementary medicine services: a review of international experiences. British Medical Bulletin, 137(1), 70-81.

  3. Chung, V. C., Wong, C. H., Zhong, C. C., Tjioe, Y. Y., Leung, T. H., & Griffiths, S. M. (2021). Traditional and complementary medicine for promoting healthy ageing in WHO Western Pacific Region: Policy implications from utilization patterns and current evidence. Integrative Medicine Research, 10(1), 100469.

  4. Wong, C. H. L., Tse, J. V. H., Nilsen, P., Ho, L., Wu, I. X. Y., & Chung, V. C (2021). Barriers and facilitators to promoting evidence uptake in Chinese medicine: a qualitative study in Hong Kong. BMC Complementary Medicine and Therapies, 21(1), 1-11.

Theme 3: Research Methods in Integrative Medicine

  1. Ho, L., Ke, F. Y., Wong, C. H., Wu, I. X., Cheung, A. K., Mao, C., & Chung, V. C. (2021). Low methodological quality of systematic reviews on acupuncture: a cross-sectional study. BMC medical Research Methodology, 21(1), 1-11.

  2. Ho, R. S., Wong, C. H., Wu, J. C., Wong, S. Y., & Chung, V. C. (2021). Non-specific effects of acupuncture and sham acupuncture in clinical trials from the patient’s perspective: a systematic review of qualitative evidence. Acupuncture in Medicine, 39(1), 3-19.

  3. Chung, V. C., Ho, R. S., Wu, X., Fung, D. H., Lai, X., Wu, J. C., & Wong, S. Y. (2015). Are meta-analyses of Chinese herbal medicine trials trustworthy and clinically applicable? A cross-sectional study. Journal of Ethnopharmacology, 162, 47-54.

  4. Wu, X. Y., Tang, J. L., Mao, C., Yuan, J. Q., Qin, Y., & Chung, V. C. (2013). Systematic reviews and meta-analyses of traditional Chinese medicine must search Chinese databases to reduce language bias. Evidence-based complementary and alternative medicine: eCAM, 2013, 812179.

Theme 4: Integrative Medicine in Pain Management

  1. Cheung, W. K. W., Wu, I. X. Y., Sit, R. W. S., Ho, R. S. T., Wong, C. H. L., Wong, S. Y. S., & Chung, V. C. (2020). Low-level laser therapy for carpal tunnel syndrome: systematic review and network meta-analysis. Physiotherapy, 106, 24-35.

  2. Sit, R. W. S., Wu, R. W. K., Rabago, D., Reeves, K. D., Chan, D. C. C., Yip, B. H. K., Chung, V. C. & Wong, S. Y. S. (2020). Efficacy of Intra-Articular Hypertonic Dextrose (Prolotherapy) for Knee Osteoarthritis: A Randomized Controlled Trial. Annals of Family Medicine, 18(3), 235.

  3. Wu, I. X., Lam, V. C., Ho, R. S., Cheung, W. K., Sit, R. W., Chou, L. W., ... & Chung, V. C. (2019). Acupuncture and related interventions for carpal tunnel syndrome: systematic review. Clinical Rehabilitation, 34(1), 34-44.

  4. Chung, V. C., Ho, R. S., Liu, S., Chong, M. K., Leung, A. W., Yip, B. H., ... & Wong, S. Y. (2016). Electroacupuncture and splinting versus splinting alone to treat carpal tunnel syndrome: a randomized controlled trial. CMAJ, 188(12), 867-875.

Theme 5: Integrative Medicine Randomized Trials and Evidence Synthesis in Functional Gastrointestinal Disorders

  1. Ho, L., Zhong, C. C., Wong, C. H., Wu, J. C., Chan, K. K., Wu, I. X., ... & Chung, V. C. (2022). Herbal medicine for functional dyspepsia: Network meta-analysis of placebo-controlled randomised trials. Journal of Ethnopharmacology, 283, 114665.

  2. Chung, V. C., Wong, C. H., Wu, I. X., Ching, J. Y., Cheung, W. K., Yip, B. H., ... & Wu, J. C. (2019). Electroacupuncture plus on-demand gastrocaine for refractory functional dyspepsia: Pragmatic randomized trial. Journal of Gastroenterology and Hepatology, 34(12), 2077-2085.

  3. Mak, A. D., Chung, V. C., Yuen, S. Y., Tse, Y. K., Wong, S. Y. S., Ju, Y., ... & Wu, J. C. Y. (2019). Noneffectiveness of electroacupuncture for comorbid generalized anxiety disorder and irritable bowel syndrome. Journal of Gastroenterology and Hepatology, 34(10), 1736-1742.

  4. Wu, I. X., Wong, C. H., Ho, R. S., Cheung, W. K., Ford, A. C., Wu, J. C., ... & Chung, V. C. (2019). Acupuncture and related therapies for treating irritable bowel syndrome: overview of systematic reviews and network meta-analysis. Therapeutic Advances in Gastroenterology, 12, 1756284818820438.

Theme 6: Diagnostic Research in Traditional Chinese Medicine

  1. Chung, V. C., Ho, R. S., Wu, X., & Wu, J. C. (2016). Incorporating traditional Chinese medicine syndrome differentiation in randomized trials: methodological issues. European Journal of Integrative Medicine, 8(6), 898-904.

  2. Ho, L. T., Chung, V. C., Wong, C. H., Wu, I. X., Lan, K. C., Wu, D., ... & Wu, J. C. (2021). Evaluating traditional Chinese medicine diagnostic instruments for functional dyspepsia: A systematic review on measurement properties. Integrative Medicine Research, 10(3), 100713.

  3. Ho, L., Zhang, N. L., Xu, Y., Ho, F. F., Wu, I. X., Chen, S., ... & Chung, V. C. (2022). Latent tree analysis for the identification and differentiation of evidence-based Traditional Chinese Medicine diagnostic patterns: A primer for clinicians. Phytomedicine, 106, 154392.

  4. Ho, L., Xu, Y., Zhang, N. L., Ho, F. F., Wu, I. X., Chen, S., ... & Chung, V. C. (2022). Quantification of prevalence, clinical characteristics, co-existence, and geographic variations of traditional Chinese medicine diagnostic patterns via latent tree analysis-based differentiation rules among functional dyspepsia patients. Chinese Medicine, 17(1), 1-23.

Last Updated: 09 February 2023

bottom of page